Clinical Trial 38858


Federal Way, WA 98003

Study Summary:

Study 38771 Flyer

PHOENIX is a phase 2 trial of the safety and efficacy of bardoxolone methyl in patients with rare chronic kidney diseases:

You May Qualify if you have been diagnosed with FSGS (Focal Segmental Glomerulosclerosis)

There are 30 participating centers in the US.

The investigational drug, study-related procedures, and doctor visits will be provided at no cost to you. You may be compensated for your time and travel.

To see if you qualify, complete the online questionnaire at

Study is Available At:

Approximately 30 research centers in the United States.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.